(Q36135663)

12 August 2017

1 reference

title

Is DNA flow cytometry a useful investigation in breast cancer? (English)

1 reference

12 August 2017

1 reference

O'Reilly SM

1

1 reference

12 August 2017

Richards MA

series ordinal

2

1 reference

12 August 2017

publication date

1 January 1992

1 reference

European Journal of Cancer

12 August 2017

published in

1 reference

12 August 2017

volume

28

1 reference

12 August 2017

issue

2-3

1 reference

12 August 2017

page(s)

504-507

1 reference

Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Estrogen receptor content and ploidy of human mammary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Ploidy Level of Human Breast Carcinoma Relation to Histopathologic Features and Hormone Receptor Content

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

A proposed classification of breast cancer based on kinetic information: derived from a comparison of risk factors in 168 primary operable breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Primary breast cancer. Flow cytometric DNA pattern in relation to clinical and histopathologic characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Prognostic significance of the DNA content of human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Tumour DNA ploidy as an independent prognostic factor in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

DNA ploidy and survival in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

DNA index, S-phase fraction, histological grade and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Flow cytometry of breast carcinoma: II. Relation of tumor cell cycle distribution to histology and estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Correlation of cell-cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction: A proposed classification of DNA histograms in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

The Multivariate Prognostic Index and nuclear DNA content are independent prognostic factors in primary breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast-cancer patients with long follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Indicators of prognosis in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

The importance of DNA flow cytometry in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Nuclear DNA content as a prognostic factor in T1-2N0 breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

How to use prognostic factors in axillary node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. Cytomorphologic changes, initial tumor ploidy, and tumor regression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Proliferative activity, histological grade and benefit from adjuvant chemotherapy in node positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Histological grade, elastosis, DNA ploidy and the response to chemotherapy of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Tumour ploidy, response and survival in patients receiving endocrine therapy for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Response to second-line hormone treatment for advanced breast cancer. Predictive value of ploidy determination

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Flow cytometric analysis of DNA content and keratins by using CK7, CK8, CK18, CK19, and KL1 monoclonal antibodies in benign and malignant human breast tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: a new view of the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980088-7

7 January 2021

10.1016/S0959-8049(05)80088-7

Identifiers

DOI

1 reference

12 August 2017

1 reference